Mainz Biomed B.V. Profile Avatar - Palmy Investing

Mainz Biomed B.V.

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product ca…

Medical - Diagnostics & Research
DE, Mainz [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Mainz Biomed B.V. (MYNZ) to it's peer group.

Peer Group
Loading...
End of MYNZ's Analysis
CIK: 1874252 CUSIP: N5436L101 ISIN: NL0015000LC2 LEI: - UEI: -
Secondary Listings
MYNZ has no secondary listings inside our databases.